Moolec Science Expands into Life Sciences and Food-Tech with Successful Business Combination

Moolec Science has successfully closed its strategic business combination with Bioceres Group, Gentle Tech, and Nutrecon, expanding its presence in life sciences and food-tech innovation. The combined company will operate under the Moolec Science name and trade on NASDAQ under the ticker symbols "MLEC" and "MLECW." Alejandro Antalich has been appointed CEO, bringing over 20 years of international leadership experience in biotechnology and life sciences.

Moolec Science SA, a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, has successfully closed its strategic business combination with Bioceres Group Limited, Gentle Technologies Corp, and Nutrecon LLC. The combined entity, operating under the Moolec Science name, will trade on NASDAQ under the ticker symbols "MLEC" and "MLECW."

The transaction, initially announced on April 17, 2025, was ratified by Moolec shareholders at an Extraordinary General Meeting (EGM) held on June 16, with approximately 77% of outstanding shares present and 98% of votes in favor. Under the terms of the deal, Bioceres Group shareholders exchanged their equity ownership for approximately 6.9 million shares of Moolec. The shareholders of 100% of Nutrecon and 50% of Gentle Tech received approximately 0.65 million shares of Moolec and 0.5 million Moolec private warrants, each with a strike price of $20.00.

Alejandro Antalich has been appointed CEO of Moolec Science. With over 20 years of international leadership experience in biotechnology and life sciences, Antalich brings a proven track record of scaling sustainable technologies and driving strategic partnerships. Prior to this appointment, he served as CEO of Nutrecon, where he positioned the company as a key innovator in precision fermentation and alternative protein ingredients.

The combined company will continue advancing its flagship molecular farming products, such as Piggy Sooy™ and GLASO™, while integrating Mycofood™ under the Eternal® brand to expand its alternative protein offering. Through Bioceres Group, Moolec will now offer upstream technologies for regenerative agriculture, including biological inputs and climate-smart seeds under the Rizobacter®, ProFarm®, and HB4® brands. With cutting-edge infrastructure through Agrality® and Synbio Powerlabs®, Moolec will benefit from in-house R&D, CDMO, and regulatory capabilities designed to accelerate its technology pipeline.

Moolec Science will also expand its presence in emerging technologies for grain and biomass transformation, particularly within the biomaterials space, as well as new concepts in farm equipment that integrate material science, electric mobility, and autonomy. These initiatives are currently being developed through subsidiaries of Gentle Tech and Bioceres Group.

References:
[1] https://www.accessnewswire.com/newsroom/en/biotechnology/moolec-science-announces-successful-closing-of-business-combination-expanding-across-1040237
[2] https://www.finanznachrichten.de/nachrichten-2025-06/65682562-moolec-science-sa-moolec-science-announces-successful-closing-of-business-combination-expanding-across-life-sciences-and-food-tech-200.htm